News
Business
Economy
Politics
Technology
Environment
Search
Friday, October 18, 2024
No menu items!
News
Business
Economy
Politics
Technology
Environment
Search
Home
Novartis to pay $245 million to end antitrust cases over Exforge drug generics
FILE PHOTO: Logo is seen at new factory of Novartis
FILE PHOTO: Logo is seen at new factory of Novartis
FILE PHOTO: The company's logo is seen at the new cell and gene therapy factory of Swiss drugmaker Novartis in Stein, Switzerland, November 28, 2019. REUTERS/Arnd Wiegmann
- Advertisment -
Most Read
U.S. chip stocks rally as TSMC’s AI-backed outlook impresses investors
October 17, 2024
Google shifts Gemini app team to DeepMind
October 17, 2024
Snap-On misses quarterly sales estimates on lower tool demand
October 17, 2024
Netflix beats earnings targets with 5 million new customers
October 17, 2024
We use cookies to ensure that we give you the best experience on our website.
Ok